Saeid Babaei

Biography

SAEID BABAEI, PH.D., MBA, CHAIRMAN OF THE BOARD Dr. Babaei has over 20 years of experience in leadership roles in the biopharmaceutical industry. He is currently Co-Founder, President, & CEO of AbCelex Technologies, a vaccine developing biotechnology company. Prior to AbCelex, Dr. Babaei has served as Vice President of Business Development at Aptose Biosciences Inc. (formerly known as Lorus Therapeutics Inc.) where he played a key role in a broad range of activities including establishing joint ventures, obtaining private financings, investor relations, and business development.     He successfully negotiated a partnership deal for Virulizin(R), a cancer immunotherapy product candidate to Zor Pharmaceuticals LLC ("ZOR"), a subsidiary of ZoticonBioventures Inc. Previously, Dr. Babaei’s served as Director of Corporate Development at Northern Therapeutics Inc, a biopharmaceutical company which develops novel cell and gene therapies, where he was instrumental in launching the ‘first’ cell-based gene therapy clinical trial for patients with pulmonary arterial hypertension. He played key roles in obtaining financings, and in securing a partnership deal with United Therapeutics. Dr. Babaei’s has served as President of AngioCell providing partnering support and advice to a range of clients on licensing, M&A, pipeline valuation, strategic planning and project financing. Dr. Babaei obtained his MBA, and Ph.D. in Laboratory Medicine & Pathobiology from University of Toronto. He is Named author for several patents, sits on several charitable boards, has lectured around the world, and has been published well over 50 times. Dr. Babaei enjoys weight lifting, travelling, and deep sea diving.

Research Interest

His research interests include drug interactions, drug excipients development, new drug discoveries, molecular modeling, herbal medical formulations, novel drug delivery systems, drug utilization studies.